Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Angel - VII | Alive

Total Raised


Last Raised

$980K | 6 yrs ago

About Vapore

Vapore is the developer of MyPurMist, a device that provides soothing hot steam on demand. The directed humidification (vapor) of MyPurMist brings warmth into the sinuses which thins mucus and makes breathing easier. The moisture in the mist helps to relieve symptoms by soothing irritated tissues in the nose and throat, calming coughs and reducing dryness.

Vapore Headquarters Location

1130 Burnett Ave Suite P

Concord, California, 94520,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Vapore Patents

Vapore has filed 5 patents.

patents chart

Application Date

Grant Date


Related Topics




Gases, Thin film deposition, Evaporators, Phase transitions, Cycle parts manufacturers


Application Date


Grant Date



Related Topics

Gases, Thin film deposition, Evaporators, Phase transitions, Cycle parts manufacturers



Latest Vapore News

Arnoldo Mondadori Editore S p A : Edizioni Piemme, UNICEF Italia and ICWA together for the rights of the child

Aug 16, 2021

08/16/2021 | 12:23pm EDT Message : *Required fields In 1991, Italy put the spotlight on the need to respect and look after children when it signed the Convention on the Rights of the Child. Thirty years later, from 18 May, the volume Dalla parte dei bambini - Il libro sui diritti dell'infanzia e dell'adolescenza , published by Edizioni Piemme-Il Battello a Vapore, in collaboration with UNICEF Italia and the ICWA (the Italian association of children's writers), is in the bookstores: an illustrated book of twenty stories by well-known Italian children's writers, inspired by the articles of the Convention. 'For us, the best way to make people aware of the rights laid out in the UN Convention is to write stories, in contemporary settings or a more evocative dimension, about children who are still denied these rights, even in developed western countries like Italy,' observes writer and ICWA President Fulvia Degl'Innocenti in the introduction to the book. 'In every story there is hope, because growing numbers of organisations and bodies are fighting to ensure these rights are fully enforced. UNICEF is the symbol of this, and its collaboration with the ICWA at various levels including this book is a powerful reflection of synergy and shared attention to childhood.' 'Il Battello a Vapore has always devoted special attention to issues of fundamental importance for children's development and education, and taken great care in how they are narrated,' explains Lorenzo Garavaldi, General Manager of the Mondadori Libri Children's Business Unit. 'Dalla parte dei bambini is a special project for us, not only because we have the honour of working together with the ICWA and UNICEF, but also because it gives us the opportunity to tell children about self-respect and respect for others. We are never too young (or too old) to learn to live in a better world and we could not have thought of a better way of celebrating the thirtieth anniversary of the Convention than by portraying it through words and pictures.' 'On 27 May we shall be celebrating the thirtieth anniversary of Italy's ratification of the Convention, which sets out the rights of every human being from their birth and recognises children not just as minors under the protection of adults, but as people with civil, social, cultural, political and economic rights,' says Carmela Pace, President of UNICEF Italia. 'We want to thank the Piemme publishing house, the Italian association of children's writers and, above all, the authors, who have contributed to this collection of stories, generously giving their time, creativity and skills to ensure that every child who reads this book will be able to identify with it, to find out something about themselves, to look at the world with new eyes and to develop an awareness of their rights.' Dalla parte dei bambini (pages: 256; price: € 13.00) is a vital tool to learn about people's rights, foster discussion and develop the awareness that every child should be listened to. The right to a name, to be listened to, to a family, to freedom of expression, thought and religion: every child is born with rights that adults must know, respect and promote. The stories of Omar who is adopted by the family of young Francesco; of Lisa, deaf from birth, who nevertheless manages to communicate with Tommaso; of Min Min, who receives a tin containing all the words she doesn't know; of Marta who decides to stand up to the bullies to protect her classmate Milan, and many others help us to listen, to understand and to be aware of our rights. The authors who took part in the project are all members of the ICWA. They are: Fabrizio Altieri, Cristina Bartoli, Stefano Bordiglioni, Patrizia Ceccarelli, Carolina D'Angelo, Emanuela Da Ros, Vichi De Marchi, Fulvia Degl'Innocenti, Giuliana Facchini, Chiara Lossani, Alberto Melis, Roberto Morgese, Daniela Palumbo, Angelo Petrosino, Livia Rocchi, Isabella Salmoirago, Manuela Salvi, Anna Sarfatti, Chiara Valentina Segré, Valentina Torchia. The illustrations are by Silvia Crocicchi. Attachments

Vapore Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vapore Rank

  • When was Vapore founded?

    Vapore was founded in 2001.

  • Where is Vapore's headquarters?

    Vapore's headquarters is located at 1130 Burnett Ave, Concord.

  • What is Vapore's latest funding round?

    Vapore's latest funding round is Angel - VII.

  • How much did Vapore raise?

    Vapore raised a total of $8.2M.

  • Who are the investors of Vapore?

    Investors of Vapore include Band of Angels, RSH Ventures and Keiretsu Forum.

  • Who are Vapore's competitors?

    Competitors of Vapore include Mirus Bio, Edge Therapeutics, Catalent, Iontera, Agentase and 10 more.

You May Also Like

Salvona Technologies Logo
Salvona Technologies

The mission statement of Salvona is to enhance people's quality of life through cutting-edge technology and the use of environmentally friendly materials and processes. Salvona has focused on developing new and advanced encapsulation and delivery systems to bridge technology gaps as well as to develop tools required to create new products that perform better, are cost effective and are environmentally friendly.


Therataxis LLC models brain transport processes and designs delivery methods for therapies. The simulation and prediction of transport mechanisms, and their direct delivery devices, provide the necessary link in developing successful therapies of the brain by ensuring proper delivery. Their currently marketed products are surgical simulation software and simulation-based device designs.

Tandem Medical

Tandem is a medical device company located in San Diego. The company manufactures and sells an automated drug delivery system primarily for use in home-administered IV's. The device is a relatively simple mechanical pump that is simpler and safer to use than standard IV therapy.

R4 Vascular Logo
R4 Vascular

Vascular is driving innovation in vascular access medical technology. The company's passion is uncomplicating venous access, chemotherapy, and drug delivery. The company's product designs offer rapid exchange, Biomimetic coating, power injection ability, and associated improvements that help the company's catheters remain patent and effective. Learn more about how the company's products can improve patient care through reduced complications, while delivering lower overall costs for access and drug delivery.


EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.


Iontera, formerly Isis Biopolymer, designs and develops intelligent transdermal drug delivery (TDD). TDD has long held the promise of non-invasive drug delivery, adding convenience, reduced costs and improved patient compliance via the application of a patch to the skin. The missing components in TDD have been controlled release of the drug carried in the patch and the breadth of drugs that can actually be transferred though skin. Iontera's patented IonIQ technology intelligently enhances and controls delivery via a single-electrode design that is governed by a programmable on-board computer.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.